Loading organizations...
§ Private Profile · Foster City, CA, USA
Biopharmaceutical company developing targeted drugs for liver disease and c
Terns Pharmaceuticals has raised $167.0M across 2 funding rounds.
Terns Pharmaceuticals has raised $167.0M in total across 2 funding rounds.
Terns Pharmaceuticals has raised $167.0M in total across 2 funding rounds.
Terns Pharmaceuticals's investors include Elise Wang, Eli Lilly and Company, Lilly Asia Ventures, OrbiMed, Samsara BioCapital, Suvretta Capital Management, Vivo Capital, Carl Gordon, Decheng Capital.
Terns Pharmaceuticals has raised $167.0M across 2 funding rounds. Most recently, it raised $87.0M Series C in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 5, 2021 | $87M Series C | Elise Wang | ELI Lilly And Company, Lilly Asia Ventures, OrbiMed, Samsara BioCapital, Suvretta Capital Management, Vivo Capital | Announced |
| Oct 30, 2018 | $80M Series B | Carl Gordon, Vivo Capital | Decheng Capital, Lilly Asia Ventures | Announced |